Duncker Streett & CO Inc Amgen Inc Transaction History

Duncker Streett & CO Inc

$542 Million
Q3 2024

A detailed history of Duncker Streett & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Duncker Streett & CO Inc holds 4,519 shares of AMGN stock, worth $1.33 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

4,519

Previous 4,128 9.47%

Holding current value

$1.33 Million

Previous $1.29 Million 12.96%

% of portfolio

0.27%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $120,967 - $131,915	391 Added 9.47%	4,519 $1.46 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $10,510 - $12,772	-40 Reduced 0.96%	4,128 $1.29 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $207,298 - $250,235	771 Added 22.7%	4,168 $1.19 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $218 - $271	1 Added 0.03%	3,397 $912,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $71,994 - $85,132	336 Added 10.98%	3,396 $753,000
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $23,482 - $28,620	-104 Reduced 3.29%	3,060 $739,000
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $14,428 - $18,333	63 Added 2.03%	3,164 $0
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $23,993 - $26,700	-104 Reduced 3.24%	3,101 $754,000
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $48,239 - $53,365	-220 Reduced 6.42%	3,205 $775,000
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $12,131 - $13,883	-61 Reduced 1.75%	3,425 $770,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $71,747 - $84,060	-338 Reduced 8.84%	3,486 $741,000
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $68,438 - $75,928	-293 Reduced 7.12%	3,824 $932,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $8,432 - $9,826	-38 Reduced 0.91%	4,117 $1.02 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $44,141 - $52,564	-204 Reduced 4.68%	4,155 $955,000
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $469 - $521	2 Added 0.05%	4,359 $1.11 Million
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $276,538 - $339,350	-1,398 Reduced 24.29%	4,357 $1.03 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $20,410 - $27,070	-112 Reduced 1.91%	5,755 $1.17 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $12,866 - $16,537	-68 Reduced 1.15%	5,867 $1.41 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $522 - $625	3 Added 0.05%	5,935 $1.15 Million
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $666 - $781	4 Added 0.07%	5,932 $1.09 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $13,022 - $14,679	72 Added 1.23%	5,928 $1.13 Million
Q4 2018 Jan 24, 2019	SELL	$178.4 - $208.25 $41,924 - $48,938	-235 Reduced 3.86%	5,856 $1.14 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $555 - $626	3 Added 0.05%	6,091 $1.26 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $9,132 - $10,258	55 Added 0.91%	6,088 $1.12 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $51,676 - $60,390	305 Added 5.32%	6,033 $1.03 Million
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $24,305 - $27,156	144 Added 2.58%	5,728 $996,000
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $934,147 - $1.07 Million	5,584	5,584 $1.04 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Account

Duncker Streett & CO Inc Amgen Inc Transaction History